Blood Clot News and Research

RSS

A Blood Clot is a mass of blood that forms when blood platelets, proteins, and cells stick together. When a blood clot is attached to the wall of a blood vessel, it is called a thrombus. When it moves through the bloodstream and blocks the flow of blood in another part of the body, it is called an embolus.

Peripheral arterial disease could predict life or death in heart patients

A growing health problem affecting older Americans puts them at higher risk for dying after heart surgery and other interventional procedures, such as heart catheterizations, according to findings published in the current edition of the Journal of the American College of Cardiology and co-authored by two leading University of Kentucky cardiologists.

23 Oct 2006

New biologic treatment for tennis elbow

A person suffering from tennis elbow may not have to look any further than his or her own body for the most effective treatment, according to a study published in the November issue of The American Journal of Sports Medicine.

23 Oct 2006

Blood clotting protein appears to also play a role in fertility

A protein known to play a role in blood clotting and other cell functions is also critical for proper sperm formation in mice, according to researchers from the University of North Carolina at Chapel Hill School of Medicine.

20 Oct 2006

Idaho woman files lawsuit over Ortho Evra patch

A woman in Idaho who said she developed a blood clot disorder after using the birth control patch Ortho Evra -- made by Ortho-McNeil, a subsidiary of Johnson & Johnson -- has filed a lawsuit in federal court against the companies, the AP/Houston Chronicle reports.

19 Oct 2006

FDA advisory panel recommends adding warning label to Tamoxifen

An FDA advisory panel on Wednesday recommended that a warning label be added to tamoxifen, an agency-approved drug for treating and preventing breast cancer, the AP/Seattle Post-Intelligencer reports (Bridges, AP/Seattle Post-Intelligencer, 10/18).

19 Oct 2006

FDA approves Zolinza for the treatment of cutaneous T-cell lymphoma

The U.S. Food and Drug Administration (FDA) has approved Zolinza (vorinostat) capsules for the treatment of cutaneous T-cell lymphoma (CTCL), a type of skin cancer, to be used when the disease persists, gets worse, or comes back during or after treatment with other medicines.

8 Oct 2006

Built-in blocker - drug and antidote in the same molecule

In cases of serious side effects or overdoses of medications, it can be vital to have a fast-acting antidote on hand.

2 Oct 2006

Sunshine Heart awarded $2.15m grant to support development of heart assist device

Sunshine Heart, Inc., today announced it has been awarded a second Commercial Ready Grant (CRG) from the Australian Government to help fund further development of its revolutionary C-Pulse heart assist device.

21 Sep 2006

Researchers create roadmap to integrin activation

Calling it an important technical advance in the study of the complex receptors and pathways of the body's cellular system, researchers at the University of California, San Diego (UCSD) School of Medicine have reconstructed the signaling pathways that impact activation of a receptor that is critical to the control of bleeding and to the thrombosis that occurs in heart attacks and strokes.

18 Sep 2006

Elective Caesarean births put babies at three times the risk of dying

Researchers in the U.S. say that babies born by Caesarean section rather than normal birth, are three times more likely to die.

7 Sep 2006

UIC receives $20 million NCI grant to research blood disorders

A $19.6 million National Cancer Institute grant has been awarded to the University of Illinois at Chicago College of Medicine to advance basic and clinical research for incurable blood disorders.

6 Sep 2006

Tenecteplase study halted

World Congress of Cardiology 2006 - Thrombolytic Therapy, given during cardiopulmonary resuscitation (CPR) in out-ofhospital cardiac arrests, may be no better than placebo.

6 Sep 2006

Ultrasound targets angioplasty

World Congress of Cardiology 2006 - A simple technique - combining cardiac ultrasound with a heart muscle-stimulating drug - can identify the MI patients who would benefit most from angioplasty after thrombolysis, reports a study in Hot Line session II.

6 Sep 2006

Test on viability of heart muscle identifies patients who will benefit from angioplasty after clot-lysing therapy for an acute heart attack

Emergency angioplasty (balloondilation of the coronary vessel) is the preferred treatment for patients with an acute heart attack. Because of its limited availability worldwide, the majority of patients who are admitted to the hospital with a heart-attack are treated with clot-lysing drugs (thrombolysis).

5 Sep 2006